Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:1.6.99.3 (diaphorase)
5,903 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Microsomes were prepared from surgical wedge biopsy specimens of the livers of 49 patients and from intact liver lobes of 9 kidney transplant donors with the objective of defining interindividual differences in the content and activities of six monooxygenase activities and their relationship to a common genetic defect in drug metabolism known as "debrisoquine polymorphism." Sixty-one patients were phenotyped in vivo with respect to their urinary metabolic ratio of debrisoquine to 4-hydroxydebrisoquine. Forty-seven patients were found to be extensive metabolizers, 12 patients were arbitrarily classified as "intermediate" metabolizers, and only 2 patients were poor metabolizers. The formation of the 4-hydroxy metabolite from debrisoquine in hepatic microsomes from extensive metabolizers was 1.33 +/- 0.437 nmol . mg protein-1 . 15 min-1 (mean +/- SD, n = 9). Microsomes of the 2 poor metabolizers formed 0.13 and 0.18 nmol 4-hydroxydebrisoquine . mg-1 . 15 min-1. Microsomes of intermediate metabolizers produced 0.464 +/- 0.115 (n = 5) of 4-hydroxydebrisoquine and were distinguished from extensive and poor metabolizers. There was no correlation between the capacity for debrisoquine hydroxylation and the total concentration of microsomal cytochrome P450, cytochrome b5, or the activities of nicotinamide adenine dinucleotide phosphate-cytochrome c reductase, aminopyrine-N-demethylase, aryl hydrocarbon hydroxylase, ethoxycoumarin-O-deethylase, aldrin epoxidase, and 2-biphenylhydroxylase. These studies indicate that genetically defective in vivo metabolism of debrisoquine is caused by a deficiency of a monooxygenase reaction in liver microsomes. Moreover, the findings suggest that direct measurement of the debrisoquine oxidation deficiency may allow the identification of heterozygous carriers of the defect. This conclusion remains to be verified by pedigree analysis.
...
PMID:Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation. 660 86

Sodium fluoride at a dose level of 5.0 mg/kg enhanced aminopyrine N-demethylase and NADPH cytochrome c reductase activities and cytochrome P450 and cytochrome b5 levels in rat liver, kidney, lung, intestine and testis, whereas acetanilide hydroxylase activity remained unchanged in kidney and lung and was increased in liver, intestine and testis. Sodium fluoride at 20.0 mg/kg caused a decrease in aminopyrine N-demethylase, acetanilide hydroxylase and NADPH cytochrome c reductase activities and cytochrome P450 and cytochrome b5 levels in all tissues, except for an increase in NADPH cytochrome c reductase activity in the intestine and testis. Fluoride at both dose levels produced only marginal changes in glutathione-S-transferase activity except for a 4-fold increase in the testis at 5.0 mg/kg. Sodium fluoride at 5.0 mg/kg increased lipid peroxidation in all tissues studied. At 20.0 mg/kg there was a decrease in lipid peroxidation in liver, lung and testis and an increase in kidney and intestine.
...
PMID:Alterations in drug metabolising enzymes and lipid peroxidation in different rat tissues by fluoride. 671 98

Biochemical aspects of b-type cytochromes in swine cerebral microsomes were different from those of cytochrome b5 in liver microsomes, as well as the difference in absorption spectra. First, the kinetic constants, Km and Vmax, in rotenone-insensitive NADH-cytochrome c reductase activity were different from those of liver microsomes, and the activity of cerebral microsomes was higher than that of liver microsomes. Second, midpoint potentials (Em) of b-type cytochromes in cerebral microsomes were measured and compared with liver microsomal cytochrome b5. In cerebral microsomes two components of b-type cytochromes were resolved, and showed Em's of -30 and +50 mV, respectively, in the presence of 2 mM KCN. On the other hand, the Em of liver microsomal cytochrome b5 was -6 mV. The high-potential component of cerebral microsomal b-type cytochromes was identified as brain-b'5 [S. Yoshida, T. Yubisui, and M. Takeshita (1983) Biochem. Int. 7, 291-298] and the low-potential component as brain-b5. The significance of the difference between cerebral and liver microsomal b-type cytochromes was discussed.
...
PMID:Characteristics of b-type cytochromes in brain microsomes: comparison with liver microsomes. 674 54

The hepatic microsomal cytochromes P-450 and b5, as well as the enzymes of the hepatic microsomal electron-transport system (HMETS), including NADPH oxidase and NAPDH cytochrome c reductase, were monitored in male ICR mice (25 - 30 g) over a six-day period following repeated oral administration of methadone hydrochloride 12.5, 25, or 50 mg/kg per day, or an equivalent volume of water. Cytochrome P-450 content, when expressed per milligram of microsomal protein, was elevated as early as day 1 of administration. This increase in cytochrome P-450, which lasted throughout the period of administration, appeared to correlate with the previously reported increase in the hepatic microsomal enzyme methadone N-demethylase and tolerance to methadone lethality. The activities of the enzymes NADPH cytochrome c reductase and NADPH oxidase were both elevated significantly by day 2 of administration. However, these increases returned to control levels by day 6 of treatment. The only other cytochrome in the HMETS, cytochrome b5, showed no significant change following repeated oral methadone administration. Further, methadone administration depressed the hepatic microsomal protein content following two days of treatment and no elevation above control values was noted. The significance of these findings with respect to the role of the HMETS in the development of tolerance is discussed in some detail for methadone, as well as the findings previously reported by this laboratory for its acetylated congener, l-alpha-acetylmethadol.
...
PMID:The role of the hepatic microsomal electron-transport system in the development of metabolic tolerance from repeated oral methadone administration in mice. 676 37

Studies were carried out to investigate the mechanism(s) responsible for the changes in adrenal microsomal mixed function oxidase activity which occur with aging (30-200 days) in guinea pigs. With aging, the rate os metabolism of xenobiotics [ethylmorphine and benzo(a)pyrene] by adrenal microsomes increased 3- to 5-fold. Steroid 17 alpha- and 21-hydroxylations, when expressed per mg protein, were similar in immature (30 days old) and mature (200 days old) animals. Adrenal microsomal NADPH- and NADH-cytochrome c reductase activities and cytochrome b5 concentrations increased wih aging, but cytochrome P-450 concentrations were not significantly different in young and old guinea pigs. Maximal type I difference spectra produced by steroids were the same in adrenal microsomes from 30- and 200-day-old guinea pigs, but the ethylmorphine-induced spectrum was far greater in the older animals. Progesterone enhanced NADPH-cytochrome P-450 reductase activity to about the same extent in adrenal microsomes from 30- and 200-day-old guinea pigs. Ethylmorphine had no effect on the rate of reduction of cytochrome P-450 in adrenals from young animals but produced a 4-fold increase in activity in adrenals from older animals. The results demonstrate selective changes in adrenal xenobiotic metabolism with aging and suggest that changes in the composition and/or reactivity of adrenal cytochromes P-450 are responsible for the effects of aging.
...
PMID:Changes in adrenal microsomal cytochrome(s) P-450 with aging in the guinea pig. 677 26

Morphine elicited a dose-related increase in the duration of phencyclidine (PCP)-induced motor incoordination. In the open field behavioral observations, morphine enhanced the PCP-induced decrease in the number of ambulation and rearing. Morphine potentiated the PCP-induced decrease in body temperature. The LD50 of PCP was significantly decreased in the presence of morphine. An opiate antagonist, naloxone, antagonized the morphine-induced effects without influencing the pharmacological actions of PCP itself. The levels of hepatic microsomal cytochrome P-450 and cytochrome b5 and the activities of NADPH dehydrogenase and NADPH cytochrome c reductase were unaffected by morphine treatment. The half-lives of PCP in serum and brain were increased by the concurrent administration of morphine. The ratio of the liver weight to body weight and aniline hydroxylase activity in hepatic microsomal fraction were decreased in the morphine-treated group compared with the control group; this is indicative of a possible reduction in the oxidative metabolism of PCP. The results indicate that acute administration of morphine enhances a variety of pharmacological effects of PCP; an inhibition of PCP disposition by morphine may be a mechanism involved in this process.
...
PMID:Effect of morphine on the responses to and disposition of phencyclidine in mice. I. Enhancement of phencyclidine effects by acute morphine administration. 684 96

NADH--cytochrome b5 reductase and cytochrome b5 associated with slow-muscle sarcoplasmic reticulum and liver microsomal fraction were identified with discrete protein bands of molecular weights 33000 and 16700 by polyacrylamide-gel electrophoresis. Purified detergent-extracted cytochrome b5 from muscle sarcoplasmic reticulum is indistinguishable from liver microsomal cytochrome b5 with respect to spectral properties, pI values and immunological reactivity with antibody to the liver cytochrome b5. Reaction of the antibody with membrane-bound cytochrome b5 inhibits the sarcoplasmic-reticulum NADH--cytochrome c reductase activity.
...
PMID:Molecular and antigenic properties of cytochrome b5 from slow-muscle sarcoplasmic reticulum. 703 20

Studies have been made of the morphology, enzyme activity and protein composition of liver endoplasmic reticulum in rats exposed to acute doses of the carcinogen, 2-acetylaminofluorene (2-AAF). Electron microscopic examination revealed numerous ultrastructural changes in the hepatocyte; most consistent alterations were the disorganisation of endoplasmic reticulum system with apparent increase of smooth endoplasmic reticulum. Administration of 2-AAF to rats immediately depressed microsomal glucose-6-phosphatase activity and eventually induced epoxide hydratase activity 6--7-fold over control activity. The induction was time-dependent and maximal rates of induction were observed at dosages greater than 40 mg/kg body wt. The treatment also induced cytochrome b5 content, NADH and NADPH cytochrome c reductase activities (1.0--1.5-fold). Only very small changes in the total content of cytochrome P-45- were noted. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of microsomal proteins from 2-AAF pretreated animals showed time-dependent induction of two polypeptides which differed slightly in migration, in the region of Mr = 48000; the fast-migrating induced polypeptide has been identified as epoxide hydratase. Two-dimensional PAGE analysis of microsomal proteins from 2-AAF exposed rats showed a reproducible deletion of a protein with molecular weight in the region of 67000. The basis for the alterations in the protein composition of endoplasmic reticulum in response to 2-AAF treatment is discussed.
...
PMID:Alterations in the enzyme activity and polypeptide composition of rat hepatic endoplasmic reticulum during acute exposure to 2-acetylaminofluorene. 707 8

Development of tolerance to phencyclidine (PCP) was assessed in male ICR mice, using motor incoordination as a parameter. The implantation of a PCP (1-3 mg/day/mouse for 1-5 days)-containing osmotic minipump, induced tolerance, as evidenced by a gradual reduction of the duration of motor incoordination. The degree of tolerance exhibited dose and time dependency. Even after the removal of the PCP pump (1 mg/day/mouse for 5 days), the tolerance remained to the same degree for at least 4 days. The hepatic microsomal cytochrome P-450, cytochrome b5 and nicotinamide adenine dinucleotide phosphatase (NADPH)-cytochrome c reductase activities were found to be elevated in tolerant mice (2 mg/day/mouse for 5 days). The half-life of PCP in the brains of tolerant mice was likewise decreased. These data indicate a dispositional tolerance for PCP. It appears that the administration of PCP by the osmotic minipump offers a convenient method for inducing PCP tolerance.
...
PMID:Development of dispositional tolerance to phencyclidine by osmotic minipump in the mouse. 710 47

The subcellular distribution of rat erythrocyte NADH-cytochrome b5 reductase was determined by radioimmunoassay, using a rabbit antibody against the cathepsin D cleaved water-soluble fragment of rat liver microsomal reductase (I-reductase), which is known to be immunologically similar to the red cell enzyme. Erythrocytes contained approximately 30 ng of reductase/mg of protein, of which 90% were recovered in the hemolysate supernatant and 2.3% in the ghost fraction. After concentration by precipitation with 70% saturated (NH4)2SO4, the NADH-cytochrome c reductase activity of the soluble enzyme could be assayed in the presence of cytochrome b5, and was found to be inhibited by anti 1-reductase antibodies. The sodium dodecyl sulfate-polyacrylamide gel electrophoretic mobilities of erythrocyte membrane-associated and soluble reductase of the liver microsomal enzyme and its cathepsin D cleaved hydrophilic fragment (I-reductase) were examined in crude fractions by blotting followed by specific and highly sensitive immunostaining. The intact microsomal enzyme and the two erythrocyte reductases all had similar mobilities and migrated behind 1-reductase. However, the ghost-associated reductase, which was not attributable to contaminating leukocyte or reticulocyte membranes, was distinguishable from the soluble form by two criteria: (i) a lower dependence on exogenous cytochrome b5 in the NADH-cytochrome c reductase assay; and (ii) a larger apparent Mr upon gel filtration in the presence of Triton X-100, presumably because of detergent binding. Considering these results, possible biogenetic relations between membrane-bound and soluble erythrocyte reductase are discussed.
...
PMID:Rat erythrocyte NADH-cytochrome b5 reductase. Quantitation and comparison between the membrane-bound and soluble forms using an antibody against the rat liver enzyme. 714 81


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>

---